Author

K. Pillai

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

D. L. Morris· 3 shared J. Akhter· 3 shared S. Valle· 3 shared A. H. Mekkawy· 2 shared S. Badar· 2 shared V. Kepenekian· 2 shared A. Mekkawy· 1 shared E. Frobert· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

D. L. Morris

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Effect of nebulised BromAc(R) on rheology of artificial sputum: relevance to muco-obstructive respiratory diseases including COVID-19

K. Pillai, A. H. Mekkawy, S. Valle, J. Akhter, D. L. Morris

This study tests the efficacy of nebulised BromAc(R) on reducing the viscosity of artificial sputum models, showing greater rheological effects than individual components.

bioRxiv · Dec 28, 2021 · PreprintMicrobiology

Bromelain and Acetylcysteine (BromAc) alone and in combination with Gemcitabine inhibits subcutaneous deposits of pancreatic cancer after intraperitoneal injection

A. H. Mekkawy, K. Pillai, S. Badar, J. Akhter, V. Kepenekian, K. Ke, S. Valle, D. L. Morris

This study evaluates BromAc alone and in combination with Gemcitabine in a pancreatic cancer mouse model, finding reduced tumor volume, weight, and Ki67 expression compared to 5-FU.

bioRxiv · May 5, 2021 · PreprintCancer Biology

The combination of Bromelain and Acetylcysteine (BromAc) synergistically inactivates SARS-CoV-2

J. Akhter, G. Queromes, K. Pillai, V. Kepenekian, S. Badar, A. Mekkawy, E. Frobert, S. Valle, D. L. Morris

This paper investigates the synergistic effect of Bromelain and Acetylcysteine (BromAc) on SARS-CoV-2, showing it fragments Spike and Envelope proteins and inactivates the virus in vitro.

bioRxiv · Sep 7, 2020 · PreprintMicrobiology